GPT and Hyperbilirubinemia: ALL therapy is prolonged for up to 3 years and is characterized by several phases of intensive chemotherapy.2 Patients can experience a plethora of adverse effects, including hepatotoxic effects, as evidenced by hyperbilirubinemia and elevated levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST).